Follow
Kathryn M. Ferguson
Title
Cited by
Cited by
Year
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
S Li, KR Schmitz, PD Jeffrey, JJW Wiltzius, P Kussie, KM Ferguson
Cancer cell 7 (4), 301-311, 2005
13312005
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors
AW Burgess, HS Cho, C Eigenbrot, KM Ferguson, TPJ Garrett, DJ Leahy, ...
Molecular cell 12 (3), 541-552, 2003
13092003
EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization
KM Ferguson, MB Berger, JM Mendrola, HS Cho, DJ Leahy, MA Lemmon
Molecular cell 11 (2), 507-517, 2003
10202003
Signal-dependent membrane targeting by pleckstrin homology (PH) domains
MA LEMMON, KM FERGUSON
Biochemical Journal 350 (1), 1-18, 2000
9992000
Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain
KM Ferguson, MA Lemmon, J Schlessinger, PB Sigler
Cell 83 (6), 1037-1046, 1995
7731995
Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain.
MA Lemmon, KM Ferguson, R O'Brien, PB Sigler, J Schlessinger
Proceedings of the National Academy of Sciences 92 (23), 10472-10476, 1995
7301995
PH domains: diverse sequences with a common fold recruit signaling molecules to the cell surface
MA Lemmon, KM Ferguson, J Schlessinger
Cell 85 (5), 621-624, 1996
6061996
The EGFR family: not so prototypical receptor tyrosine kinases
MA Lemmon, J Schlessinger, KM Ferguson
Cold Spring Harbor perspectives in biology 6 (4), a020768, 2014
4802014
Structure-based view of epidermal growth factor receptor regulation
KM Ferguson
Annu. Rev. Biophys. 37, 353-373, 2008
4682008
Identification and analysis of PH domain‐containing targets of phosphatidylinositol 3‐kinase using a novel in vivo assay in yeast
SJ Isakoff, T Cardozo, J Andreev, Z Li, KM Ferguson, R Abagyan, ...
The EMBO journal, 1998
4341998
Structural basis for discrimination of 3-phosphoinositides by pleckstrin homology domains
KM Ferguson, JM Kavran, VG Sankaran, E Fournier, SJ Isakoff, ...
Molecular cell 6 (2), 373-384, 2000
4132000
Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface
JP Dawson, MB Berger, CC Lin, J Schlessinger, MA Lemmon, ...
Molecular and cellular biology 25 (17), 7734-7742, 2005
4062005
Crystal structure at 2.2 Å resolution of the pleckstrin homology domain from human dynamin
KM Ferguson, MA Lemmon, J Schlessinger, PB Sigler
Cell 79 (2), 199-209, 1994
3491994
Pleckstrin homology domains and the cytoskeleton
MA Lemmon, KM Ferguson, CS Abrams
FEBS letters 513 (1), 71-76, 2002
3442002
EGFR ligands differentially stabilize receptor dimers to specify signaling kinetics
DM Freed, NJ Bessman, A Kiyatkin, E Salazar-Cavazos, PO Byrne, ...
Cell 171 (3), 683-695. e18, 2017
3142017
A biparatopic anti‐EGFR nanobody efficiently inhibits solid tumour growth
RC Roovers, MJWD Vosjan, T Laeremans, R el Khoulati, RCG de Bruin, ...
International journal of cancer 129 (8), 2013-2024, 2011
2842011
The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand
S Bouyain, PA Longo, S Li, KM Ferguson, DJ Leahy
Proceedings of the National Academy of Sciences 102 (42), 15024-15029, 2005
2632005
Structural evaluation of EGFR inhibition mechanisms for nanobodies/VHH domains
KR Schmitz, A Bagchi, RC Roovers, PMPB en Henegouwen, ...
Structure 21 (7), 1214-1224, 2013
2192013
Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization
J Schmiedel, A Blaukat, S Li, T Knöchel, KM Ferguson
Cancer cell 13 (4), 365-373, 2008
2042008
Regulatory recruitment of signalling molecules to the cell membrane by pleckstrinhomology domains
MA Lemmon, M Falasca, J Schlessinger, K Ferguson
Trends in Cell Biology 7 (6), 237-242, 1997
1931997
The system can't perform the operation now. Try again later.
Articles 1–20